Investor Relations

Press Releases

 
Press Releases
  Date Title View
Jun 29, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 29, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the appointment of Dean Judy D. Olian, Ph.D. to its Board of Directors as an independent director.  The appointment is effective as of June 26, 2015. Olian is the dean of the UCLA Anderson School o...
Jun 15, 2015
SILVER SPRING, Md., and RESEARCH TRIANGLE PARK, N.C., June 15, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced receipt of a Paragraph IV Certification Notice Letter from Watson Laboratories, Inc. (Watson) advising that Watson has submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Admin...
May 29, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 29, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Jefferies 2015 Global Healthcare Conference in...
May 1, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 1, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Deutsche Bank 40th Annual Health Care Conferenc...
Apr 28, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 28, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2015. "Our total revenues increased as compared to the prior year and we are continuing to see a growing number of patients being prescr...
Apr 21, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 21, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2015 financial results before market open on Tuesday, April 28, 2015. United Therapeutics will host a half-hour teleconference on Tuesday, April 28, 2015, at...
Mar 10, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 10, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA), as part of the Biologics License Application approval for Unituxin, awarded United Therapeutics a Rare Pediatric Priority Review Voucher (PPRV) ...
Mar 10, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 10, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA) has approved Unituxin™ (dinutuximab) Injection (formerly called ch14.18), in combination with granulocyte-macrophage colony-stimulating fac...
Feb 25, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 25, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Cowen and Company 35th Annual Healthcare...
Feb 24, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2014. "Our overall revenues and profits grew significantly from 2013 to 2014, and we are pleased to see continued growth in ...
1
... NextLast
= add release to Briefcase